facebook

traded

+ Submit
Home

/

Deals

/

Massachusetts

/

Life Sciences

/

Loan

/

441 Morgan Avenue

DivcoWest Secures $341.3M Refinance From KKR For Life Sciences Asset In Cambridge, MA
FINANCEDLife Sciences

DivcoWest Secures $341.3M Refinance From KKR For Life Sciences Asset In Cambridge, MA

441 Morgan Avenue

$341,300,000

$916/SF

Building Size

372,366 SF

Asset Type

Life Sciences

Closing

Mar 31, 2026

AI

The asset involved in this transaction is a 372,366-square-foot life sciences building located at 441 Morgan Avenue in Cambridge, MA. The property, part of Cambridge Crossing, has been refinanced for an amount of $341,300,000. This refinancing replaces a previous construction loan of $401,000,000 issued in 2021 for this LEED Platinum building, which is partly leased to Astellas Pharma Inc.

Summary of transaction details:

  • Property Type: Life Sciences
  • Transaction Amount: $341,300,000
  • Lender: Joseph Bae & Scott Nuttall - KKR
  • Landlord: Stuart Shiff - DivcoWest
  • Previous Loan Amount: $401,000,000
  • Asset Delivery Year: 2024

This refinancing deal features key individuals such as Joseph Bae and Scott Nuttall from KKR, who served as the lenders. The landlord of the property, Stuart Shiff, represents DivcoWest in this transaction. The deal specifically aims to replace the initial construction financing that was established for the future use of the building.

Players

Joseph Bae

KKR

Lender

$2.6B

vol

14 deals

Lender
Stuart Shiff

Stuart Shiff

DivcoWest

Landlord

$2.2B

vol

16 deals

Landlord

Cambridge Life Sciences Market Snapshot

Boundary boundary · Life Sciences · Loan transactions

Loading comparables…

Purchase Price

Annual NOI

Loan Amount

Interest Rate (%)

Loan Term (yrs)

Down Payment (%)

Cap Rate

0.05%

Cash-on-Cash

-0.01%

Monthly Payment

$14,164

Annual Debt Svc

$169,964

Annual Cash Flow

$-11,334

DSCR

0.93